Literature DB >> 16638359

[Classification and surgical treatment of intrathoracic esophageal injury caused by foreign body].

Sheng Chang1, Bang-chang Cheng, Jie Huang, Zhi-fu Mao, Tu-sheng Wang, Jun Xia.   

Abstract

OBJECTIVE: To investigate the classification criterion and surgical treatment strategy of intrathoracic esophageal injury caused by foreign body.
METHODS: Eighty-four patients with intrathoracic esophageal injury caused by foreign body in our department from January 1980 to April 2004 were divided into 4 grade: grade I was non-penetrated injury of esophagus (18 cases); grade II was esophageal perforation with mild mediastinitis (39 cases); grade III was esophageal perforation with severe intrathoracic infection (17 cases); grade IV was aortoesophageal fistula (10 cases). Based on the degree of esophageal injury and the extension of inflammation, operative procedures were selected including esophagotomy, esophageal reparation, esophagectomy, mediastinal drainage, reparation of fistula and replacement of aorta.
RESULTS: Patients in grade I and II were all cured . One death occurred in grade III (1/17), the same in Grade IV was 9 (9/10).
CONCLUSIONS: Classification of esophageal injury caused by foreign body is helpful to the decision of surgical treatment strategy. The prevention of aortoesophageal fistula is the key point of reducing of mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16638359

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  2 in total

1.  Proposed management protocol for ingested esophageal foreign body and aortoesophageal fistula: a single-center experience.

Authors:  Yiping Wei; Liru Chen; Yiming Wang; Dongliang Yu; Jinhua Peng; Jianjun Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Massive Hematemesis as Presentation of Congenital Aortic Coarctation With Superinfected Aneurysm and Aortoesophageal Fistula.

Authors:  Melissa A Sheiko; Edward J Hoffenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-01       Impact factor: 2.839

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.